Medtronic implant found better at predicting AFib than external device

(Image courtesy of University of Alberta)

A Medtronic implant was three times better than an external monitor at detecting new atrial fibrillation in stroke patients, a new study says.

The Post-Embolic Rhythm Detection With Implantable Versus External Monitoring (PER DIEM) study pitted Medtronic’s Reveal Linq implantable device, which monitors for AFib over 12 months, against the Spiderflash-T external device made by Sorin Group, which works over a 30-day period.

Get the full story on our sister site, Medical Design & Outsourcing.

Read more
  • 0